SCHEMBL8201684

SCHEMBL8201684

Clc1nc(NCCCCc2ccccc2)c2ncn(C3CCCC3)c2n1.Clc1nc(NCCCCc2ccccc2)c2ncn(C3CCCC3)c2n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.64
ADORA1 P30542 3/20 0.64
ADORA2A P29274 1/20 0.63
CDK1 P06493 6/20 0.59
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
TSHR P16473 1/20 0.55
CYP2C19 P33261 1/20 0.55
CTSL P07711 3/20 0.55
FLT3 P36888 2/20 0.51
CCNB2 O95067 1/20 0.51
CCNE2 O96020 1/20 0.51
CDK4 P11802 1/20 0.51
CCNB1 P14635 1/20 0.51
CCND1 P24385 1/20 0.51
CCNE1 P24864 1/20 0.51
CDK2 P24941 1/20 0.51
CCNB3 Q8WWL7 1/20 0.51
CDK5 Q00535 2/20 0.50
HDAC1 Q13547 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6821051 1.00 ADORA3 (0.64) ADORA3ADORA1ADORA2ACDK1CYP2D6
SCHEMBL6821666 0.97 ADORA3 (0.60) ADORA3ADORA1ADORA2ACDK1CYP2D6
SCHEMBL6817845 0.93 CYP2D6 (0.64) ADORA3ADORA1ADORA2ACDK1CYP2D6
SCHEMBL5193141 0.86 CDK1 (0.78) ADORA3ADORA1ADORA2ACDK1CTSL
SCHEMBL5196991 0.86 CDK1 (0.64) ADORA3ADORA1ADORA2ACDK1CYP2D6
SCHEMBL6944712 0.85 CDK1 (0.57) ADORA3ADORA1CDK1CYP2D6CYP2C9
SCHEMBL6820861 0.84 CDK1 (0.54) ADORA3ADORA1ADORA2ACDK1CYP2D6
SCHEMBL6824196 0.84 CTSL (0.56) ADORA3ADORA1ADORA2ACDK1CTSL
SCHEMBL6817879 0.84 CTSL (0.70) ADORA3ADORA1CDK1CTSLFLT3
SCHEMBL6817663 0.83 CTSL (0.72) ADORA3ADORA1ADORA2ACDK1CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056745-A2 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES Aventis Pharmaceuticals Inc. (US) 2000-12-06 EP disclosed
WO-1999043676-A2 6,9-DISUBSTITUTED 2-[TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES AVENTIS PHARMACEUTICALS INC. (US) 1999-09-02 WO disclosed